Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Fulminant Demyelinating Diseases of the Central Nervous System.
The role of invariant NKT cells in organ-specific autoimmunity.
Erratum to: Altered serotonin transporter availability in patients with multiple sclerosis.
Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.
Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.
[Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy].
Monitoring of active human herpes virus 6 infection in Iranian patients with different subtypes of multiple sclerosis.
Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review.
Dietary habits and selenium, glutathione peroxidase and total antioxidant status in the serum of patients with relapsing-remitting multiple sclerosis.
Neuromuscular adaptations to long-term progressive resistance training translates to improved functional capacity for people with multiple sclerosis and is maintained at follow-up.
Levetiracetam for neuropathic pain in adults.
Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.
Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways.
[Current aspects of therapy conversion for multiple sclerosis].
Diffusional kurtosis imaging of normal-appearing white matter in multiple sclerosis: preliminary clinical experience.
Developing connections amongst key cytokines and dysregulated germinal centers in autoimmunity.
Histamine H2 receptor signaling x environment interactions determine susceptibility to experimental allergic encephalomyelitis.
Case-Based fMRI Analysis after Cognitive Rehabilitation in MS: A Novel Approach.
The Association of Depression with Pain-Related Treatment Utilization in Patients with Multiple Sclerosis.
Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females.
Progesterone's role in neuroprotection, a review of the evidence.
Topography of brain sodium accumulation in progressive multiple sclerosis.
In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response.
SLAM-SAP Signaling Promotes Differentiation of IL-17-Producing T Cells and Progression of Experimental Autoimmune Encephalomyelitis.
CONTINUUM Multiple Sclerosis: Teaching Us About More Than MS and Its ABCs.
Pages
« first
‹ previous
…
375
376
377
378
379
380
381
382
383
…
next ›
last »